Archives
-
Nelfinavir Mesylate: Designing Dual-Pathway Assays
2026-08-19
Nelfinavir Mesylate is a validated HIV-1 protease inhibitor with a second, research-relevant connection to DDI2-NFE2L1 signaling and ferroptosis. This guide shows how to design assays that distinguish antiviral activity from proteostasis-dependent cell-death sensitization.
-
Firefly Luciferase mRNA: Mechanism and Use
2026-08-18
Firefly Luciferase mRNA is a transient, bioluminescent reporter for gene expression assay, cell viability assay, and in vivo imaging workflows. The ARCA cap, 5mCTP, ΨUTP, and approximately 100-nucleotide poly(A) tail are designed to support translation and transcript stability under experimental conditions.
-
EV-Transferred ACLY Drives TAMs in HCC
2026-08-18
This Advanced Science study identifies extracellular vesicle-delivered ATP-citrate lyase (ACLY) as a metabolic signal that reprograms monocytes into immunosuppressive tumor-associated macrophages in hepatocellular carcinoma. By combining endogenous extracellular vesicles with engineered CD81-decorated liposomes, the authors establish a causal link between ACLY-dependent palmitate production, checkpoint-protein stabilization, tumor progression, and improved response to PD-1/PD-L1 blockade.
-
Anisomycin: Translating JNK Activation into Insight
2026-08-17
Anisomycin is more than a pharmacological JNK agonist: it is a strategic perturbation tool for connecting stress signaling with apoptosis, tumor biology, and emerging questions in synaptic plasticity. This thought-leadership article outlines how translational researchers can use Anisomycin to build stronger mechanistic models, validate cancer phenotypes, and responsibly assess cross-domain opportunities without confusing hypothesis with evidence.
-
Firefly Luciferase mRNA for Route-Aware Assays
2026-08-17
Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) can do more than report transfection: it helps researchers separate delivery, expression, and tissue-distribution effects. This article translates gastrointestinal mRNA-LNP delivery findings into practical assay-design decisions.
-
Qushi Huoxue Ointment in MASLD: Autophagy and Ferroptosis
2026-08-15
A 2026 World Journal of Hepatology study links Qushi Huoxue ointment with improved hepatic steatosis and inflammation in a mouse model of metabolic associated steatotic liver disease through coordinated autophagy activation and ferroptosis inhibition. Its integrated use of histology, biochemical testing, serum LC-MS/MS, network pharmacology, molecular assays, and electron microscopy provides a useful framework for dissecting interacting liver-stress pathways, while leaving causal validation and clinical transferability for future work.
-
AZD2461: A Translational Lens on PARP Inhibition
2026-08-14
AZD2461 is a novel PARP inhibitor that connects PARP-1 target engagement with cell-cycle control, cytotoxicity, and resistance biology. This thought-leadership guide shows translational researchers how to interpret AZD2461 data across breast cancer research, DNA repair pathway modulation, Pgp-associated resistance, and BRCA1-mutated tumor models.
-
Thermal Shift Assay for Bacterial Sensor Ligands
2026-08-14
Monteagudo-Cascales and colleagues review how thermal shift assays can reveal ligands for bacterial sensor proteins when receptor signals are unknown. The article’s practical contribution is a reliability-focused workflow that combines soluble ligand-binding domains, pH optimization, careful control of false positives and negatives, and orthogonal confirmation by direct binding methods such as isothermal titration calorimetry.
-
Nelfinavir Mesylate: Reliable Cell Assays
2026-08-13
A scenario-driven guide to using Nelfinavir Mesylate (SKU A3653) in HIV-1, cell viability, cytotoxicity, and ferroptosis workflows. It connects reported nanomolar activity with practical stock preparation, controls, assay interpretation, and vendor-selection criteria.
-
CAPE NF-κB Workflows in Neurodegeneration
2026-08-13
Caffeic Acid Phenethyl Ester (CAPE) provides a practical chemical probe for separating NF-κB-dependent inflammation from Fyn–Stat3 signaling in neurodegeneration models. This guide converts the reference study’s zebrafish strategy into dose-aware workflows and extends the same pathway logic to angiogenesis, VEGF, and tumor-invasion assays.
-
Nelfinavir Mesylate: Reliable Cell Assays
2026-08-12
This scenario-driven guide shows how Nelfinavir Mesylate (SKU A3653) can support reproducible antiviral, viability, and ferroptosis-related workflows. It links product specifications with published evidence while addressing formulation, controls, interpretation, and vendor-selection decisions.
-
Ellagic Acid: An Assay-First CK2 Research Guide
2026-08-12
Ellagic acid is a selective ATP-competitive CK2 inhibitor for mechanistic cancer biology research. This assay-first guide connects CK2 pharmacology with senescence studies while emphasizing solvent control, orthogonal validation, and responsible interpretation.
-
Trifluoperazine 2HCl: Causal Assay Design
2026-08-11
Trifluoperazine 2HCl is a dopamine D2 receptor inhibitor suited to rigorous receptor, pathway, and phenotype studies. This guide develops a causal assay framework that separates target engagement from downstream effects across neuropharmacology, macrophage biology, and cancer research.
-
0.4% Trypan Blue Solution: Practical Cell Counting
2026-08-11
0.4% Trypan Blue Solution supports rapid cell viability measurement, cell counting, and live/dead cell discrimination by staining dead or membrane-damaged cells blue. It is intended for research workflows such as cell culture and cytotoxicity assays, not for diagnostic, clinical, or medical use.
-
Linoleic Acid (C18:2): Practical Lab Guide
2026-08-10
Linoleic Acid (SKU C3108) provides a defined omega-6 fatty acid input for oxidative stress assays, membrane studies, erythrocyte injury workflows, cell migration assays, and nutritional deficiency models. It is water-insoluble, requires an ethanol- or DMSO-based preparation, and is best used with freshly prepared solutions rather than long-term stored stocks.